• Register
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.


Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.


FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.

To better understand the signaling properties of oncogenic FGFR3, we performed phospho-proteomics studies to identify potential downstream signaling effectors that are tyrosine phosphorylated in hematopoietic cells expressing constitutively activated leukemogenic FGFR3 mutants. We found that FGFR3 directly tyrosine phosphorylates the serine/threonine kinase p90RSK2 at Y529, which consequently regulates RSK2 activation by facilitating inactive ERK binding to RSK2 that is required for ERK-dependent phosphorylation and activation of RSK2. Moreover, inhibition of RSK2 by siRNA or a specific RSK inhibitor fmk effectively induced apoptosis in FGFR3-expressing human t(4;14)-positive myeloma cells. Our findings suggest that FGFR3 mediates hematopoietic transformation by activating RSK2 in a two-step fashion, promoting both the ERK-RSK2 interaction and subsequent phosphorylation of RSK2 by ERK.

Pubmed ID: 17785202


  • Kang S
  • Dong S
  • Gu TL
  • Guo A
  • Cohen MS
  • Lonial S
  • Khoury HJ
  • Fabbro D
  • Gilliland DG
  • Bergsagel PL
  • Taunton J
  • Polakiewicz RD
  • Chen J


Cancer cell

Publication Data

September 5, 2007

Associated Grants

  • Agency: NCI NIH HHS, Id: CA120272
  • Agency: NCI NIH HHS, Id: R01 CA120272
  • Agency: NCI NIH HHS, Id: R01 CA120272-02

Mesh Terms

  • Apoptosis
  • Binding Sites
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Enzyme Activation
  • Extracellular Signal-Regulated MAP Kinases
  • Humans
  • MAP Kinase Signaling System
  • Mitogen-Activated Protein Kinase Kinases
  • Models, Biological
  • Multiple Myeloma
  • Phosphorylation
  • RNA Interference
  • Receptor, Fibroblast Growth Factor, Type 3
  • Ribosomal Protein S6 Kinases, 90-kDa
  • Tyrosine